| Distinct TCR signaling pathways drive proliferation and cytokine production in T cells CS Guy, KM Vignali, J Temirov, ML Bettini, AE Overacre, M Smeltzer, ... Nature immunology 14 (3), 262-270, 2013 | 258 | 2013 |
| Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia B Li, SW Brady, X Ma, S Shen, Y Zhang, Y Li, K Szlachta, L Dong, Y Liu, ... Blood, The Journal of the American Society of Hematology 135 (1), 41-55, 2020 | 216 | 2020 |
| Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial S Shen, X Chen, J Cai, J Yu, J Gao, S Hu, X Zhai, C Liang, X Ju, H Jiang, ... JAMA oncology 6 (3), 358-366, 2020 | 186 | 2020 |
| Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia ML Churchman, M Qian, G Te Kronnie, R Zhang, W Yang, H Zhang, ... Cancer cell 33 (5), 937-948. e8, 2018 | 175 | 2018 |
| TP53 germline variations influence the predisposition and prognosis of B-cell acute lymphoblastic leukemia in children M Qian, X Cao, M Devidas, W Yang, C Cheng, Y Dai, A Carroll, ... Journal of clinical oncology 36 (6), 591, 2018 | 152 | 2018 |
| Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP M Qian, H Zhang, SKY Kham, S Liu, C Jiang, X Zhao, Y Lu, C Goodings, ... Genome research 27 (2), 185-195, 2017 | 125 | 2017 |
| A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults V Perez-Andreu, KG Roberts, H Xu, C Smith, H Zhang, W Yang, ... Blood, The Journal of the American Society of Hematology 125 (4), 680-686, 2015 | 122 | 2015 |
| CAR-T cell therapy in hematological malignancies: current opportunities and challenges X Zhang, L Zhu, H Zhang, S Chen, Y Xiao Frontiers in immunology 13, 927153, 2022 | 114 | 2022 |
| Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nature Communications 6, 2015 | 83 | 2015 |
| Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2) WH Zhao, BY Wang, LJ Chen, WJ Fu, J Xu, J Liu, SW Jin, YX Chen, ... Journal of Hematology & Oncology 15 (1), 86, 2022 | 69 | 2022 |
| PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia Y Zhang, Y Gao, H Zhang, J Zhang, F He, A Hnízda, M Qian, X Liu, ... Blood, The Journal of the American Society of Hematology 131 (20), 2256-2261, 2018 | 68 | 2018 |
| Anti-CLL1 chimeric antigen receptor T-cell therapy in children with relapsed/refractory acute myeloid leukemia H Zhang, P Wang, Z Li, Y He, W Gan, H Jiang Clinical Cancer Research 27 (13), 3549-3555, 2021 | 62 | 2021 |
| Giant photovoltaic effects driven by residual polar field within unit-cell-scale LaAlO3 films on SrTiO3 H Liang, L Cheng, X Zhai, N Pan, H Guo, J Zhao, H Zhang, L Li, X Zhang, ... Scientific reports 3 (1), 1975, 2013 | 60 | 2013 |
| Preferential eradication of acute myelogenous leukemia stem cells by fenretinide H Zhang, JQ Mi, H Fang, Z Wang, C Wang, L Wu, B Zhang, M Minden, ... Proceedings of the National Academy of Sciences 110 (14), 5606-5611, 2013 | 60 | 2013 |
| Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial W Yang, J Cai, S Shen, J Gao, J Yu, S Hu, H Jiang, Y Fang, C Liang, X Ju, ... The Lancet Oncology 22 (9), 1322-1332, 2021 | 59 | 2021 |
| Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation J Tang, J Yu, J Cai, L Zhang, S Hu, J Gao, H Jiang, Y Fang, C Liang, X Ju, ... Blood, The Journal of the American Society of Hematology 138 (4), 331-343, 2021 | 57 | 2021 |
| Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response H Ding, H Zhang, H Ding, D Li, X Yi, X Ma, R Li, M Huang, X Ju Cellular & Molecular Immunology 14 (8), 693-701, 2017 | 57 | 2017 |
| Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics M Qian, H Xu, V Perez-Andreu, KG Roberts, H Zhang, W Yang, S Zhang, ... Blood, The Journal of the American Society of Hematology 133 (7), 724-729, 2019 | 46 | 2019 |
| Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia W Stock, G Martinelli, M Stelljes, DJ DeAngelo, N Gökbuget, AS Advani, ... Cancer 127 (6), 905-913, 2021 | 38 | 2021 |
| Successful anti-CLL1 CAR T-cell therapy in secondary acute myeloid leukemia H Zhang, WT Gan, WG Hao, PF Wang, ZY Li, LJ Chang Frontiers in oncology 10, 685, 2020 | 38 | 2020 |
